article thumbnail

FDA reviewers back Pfizer/BioNTech COVID-19 vaccine ahead of panel

pharmaphorum

The gist of a briefing document published from FDA reviewers ahead of an expert advisory board meeting is that the vaccine is good to go. But there are still unanswered questions that can only be addressed once the shot is administered to the wider public. of participants.

Vaccines 111
article thumbnail

Pharmacovigilance deep dive: risk minimisation measures

European Pharmaceutical Review

This can be achieved by reducing the burden of adverse reactions or by optimising benefits through patient selection (eg, contraindications, recommendations of use, warnings, concomitant medicine[s], or certain test parameters) and treatment management (eg, specific dosing regimen, relevant testing, patient follow-up).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NICE says yes to BeiGene’s Brukinsa after Scottish nay

pharmaphorum

The final appraisal document from health technology assessment (HTA) agency NICE says that Brukinsa can be used to treat WM in adults who have had at least one prior treatment, and only if bendamustine plus rituximab therapy is also suitable.

article thumbnail

How using AI in clinical trials accelerates drug development

Pharmaceutical Technology

During these phases, data is obtained from participants and monitored for adverse reactions or changes to health indicators, such as blood pressure or heart rate. For example, important information may be locked in knowledge silos or gained through experience, making it difficult to find or document.

article thumbnail

How to Run DMC? It’s Tricky – FDA’s New Draft Guidance Provides Updated Recommendations on How to Best Use Data Monitoring Committees in Clinical Trials

The FDA Law Blog

Other Oversight Groups Both documents described the role of other oversight groups, in addition to DMCs, that may be involved in a clinical trial in similar, sometimes overlapping, roles such as IRBs, trial steering committees, and site monitors. Increased Connections Between a DMC and FDA?

article thumbnail

Overdoses come in many forms

PharmD Live

For example, documents show that type 2 diabetes increases interleukin-6 (IL-6) in plasma, among other effects. Because of this it is imperative patients on multiple medications receive close monitoring for signs of adverse reactions. That means a patient may have supratherapeutic levels of the drugs prescribed.

article thumbnail

How advanced technology can streamline the COVID-19 vaccine rollout

pharmaphorum

Adverse reactions to the vaccine. The data must be quickly documented and reported to public health agencies to ensure effective record keeping, equal access to the vaccine and patient safety. In a rollout of this magnitude, point of care facilities need to collect comprehensive vaccination data on: Individual patient records.

Vaccines 119